SCHEMBL7426853

SCHEMBL7426853

CCCc1c(C(C)=O)c2ccc(C(N)=O)cc2n1Cc1cc2c(cc1Cl)OCO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.40
CHEK2 O96017 2/20 0.38
EDNRA P25101 5/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
LMNA P02545 3/20 0.36
TSHR P16473 1/20 0.36
EDNRB P24530 4/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
HTT P42858 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP2C9 P11712 1/20 0.34
HPGD P15428 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPK1 P28482 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7424082 0.92 SLC22A12 (0.42) SLC22A12EDNRASMN1; SMN2LMNATSHR
SCHEMBL7427382 0.90 SLC22A12 (0.39) SLC22A12CHEK2EDNRASMN1; SMN2LMNA
SCHEMBL7418953 0.89 EDNRA (0.39) SLC22A12CHEK2EDNRAEDNRBCYP1A2
SCHEMBL7423537 0.89 MEN1 (0.40) SLC22A12EDNRASMN1; SMN2LMNATSHR
SCHEMBL7426123 0.89 SLC22A12 (0.39) SLC22A12CHEK2EDNRASMN1; SMN2LMNA
SCHEMBL7426188 0.88 EDNRA (0.38) SLC22A12CHEK2EDNRAEDNRBCYP1A2
SCHEMBL7420854 0.88 EDNRA (0.38) SLC22A12CHEK2EDNRAEDNRBCYP1A2
SCHEMBL7422738 0.88 EDNRA (0.38) SLC22A12CHEK2EDNRAEDNRBCYP1A2
SCHEMBL7420199 0.86 SLC22A12 (0.37) SLC22A12CHEK2EDNRASMN1; SMN2EDNRB
SCHEMBL7427422 0.84 NPC1 (0.37) SLC22A12CHEK2EDNRASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed